ScholarMate
English简体中文繁體中文
Customer service: 400-1616-289
Sign inSign up
Journal article

Efficacy of the Integrative Acupuncture and Moxibustion Treatment in Patients With Major Depressive Disorder: The Study Protocol for a Multicenter, Single-Blinded, Randomized Trial in China

Zhang, Yuan; Liu, Yamin; Ning, Baile; Yan, Luda; Wu, Lihua; Zhang, Delong; Li, Changhong; Ouyang, Wenwei; Su, Shengyong; Jiang, Shuo; Zhang, Guangcai; Xu, Junfeng; Wang, Zhen; Zheng, Zhong; Zheng, Dong; Chen, Shan; Sun, Lu*; Fu, Wenbin*广东教育学院; 广东省人民医院; 广州医学院; 广州中医药大学; 四川大学; 中国医科大学; 1
Frontiers in Medicine2022-5-30DOI: 10.3389/fmed.2022.761419
2Cited by7Reads
CiteSave
Share

Abstract

Introduction: Antidepressants are the front-line treatments for major depressive disorder (MDD), but remain unsatisfactory in outcome. An increasing number of patients are interested in acupuncture and moxibustion treatment as complementary therapies. This study aims to evaluate the efficacy and safety of integrative acupuncture and moxibustion (iAM) treatment in patients with MDD. Methods and Analysis: This multicenter, single-blind, 2 x 2 factorial randomized trial will enroll 592 patients with MDD of moderate severity from nine hospitals. All patients will be randomized, in a ratio of 2:2:2:1, through a computerized central randomization system, into four groups (the combined, iAM-only, sertraline-only, and placebo groups). Participants will undergo a 12-week intervention with either 50 mg of sertraline or a placebo once a day and active/sham iAM treatment three times per week. The primary outcome is depression severity, assessed using the Hamilton Depression Scale-17. The secondary outcomes include self-rated depression severity, anxiety, and sleep quality. The primary and secondary outcomes will be measured at weeks 0, 4, 8, 12, and the 8th week posttreatment. Safety will be evaluated through liver and kidney function tests conducted before and after treatment and through monitoring of daily adverse events. An intent-to-treat principle will be followed for the outcome analyses. Conclusion: This trial will provide sufficient evidence to ascertain whether iAM is effective and safe for treating MDD and provides a suitable combination strategy for treating MDD.

Disciplines and keywords

Keywords
acupuncturemoxibustionauricular acupunctureintegrative treatmentdepressive disorderssertraline
Related
Loading…

Could not load papers. Please retry.

Retry

Publication info

Publication status
Published
Journal
Frontiers in Medicine
Publication date
2022-05-30
Volume / issue
Vol. 9
Pages
761419
DOI
10.3389/fmed.2022.761419
Journal ranking
Q3
Output indexing
SCIE
Funding acknowledgment
Universiti Teknologi MARA [600-RMC/GPK 5/3(229/2020)]

Authors

  • Z

    Zhang, Yuan (First author)

    2 · guangzhou univ chinese med

  • L

    Liu, Yamin

    guangzhou univ chinese med

View all 18 authorsShow fewer authors
  • N

    Ning, Baile

    2 · guangzhou univ chinese med

  • Y

    Yan, Luda

    guangzhou univ chinese med

  • W

    Wu, Lihua

    guangzhou univ chinese med

  • Z

    Zhang, Delong

  • L

    Li, Changhong

    guangdong univ educ

  • O

    Ouyang, Wenwei

    2 · guangzhou univ chinese med

  • S

    Su, Shengyong

    1 · chinese med univ

  • J

    Jiang, Shuo

    1 · zhejiang chinese med univ

  • Z

    Zhang, Guangcai

    hainan prov hosp

  • X

    Xu, Junfeng

    1 · chinese med univ

  • W

    Wang, Zhen

    2 · chinese med univ

  • Z

    Zheng, Zhong

    sichuan univ

  • Z

    Zheng, Dong

    guangzhou med univ

  • C

    Chen, Shan

    2 · guangzhou univ chinese med

  • S

    Sun, Lu (Corresponding)

    guangdong prov hosp

  • F

    Fu, Wenbin (Corresponding)

    2 · guangzhou univ chinese med

Sign in for more features

  • Save this paper in My collections
  • Claim your outputs and generate promotion materials
  • Follow authors for new outputs
  • Join groups and collaborate
Sign up / Sign in

Products

  • ScholarMate
  • InnoCity
  • IRISaaS

Support

  • Help Center
  • Privacy Policy
  • Terms of Service

Contact

Online support: []
Customer service: 400-1616-289
Email: support@scholarmate.com

Follow or download ScholarMate

WeChat QR code
WeChat official account
App download QR code
Download the app
OutputsResearchersResearch institutionsResearch newsIRISaaS

©2026 深圳市科研之友网络服务有限公司

Public security registration badge粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417